// App-Quantinova.ai

TCT-568 : Real Polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multi-center, randomized, prospective trial

Researchers

Presenter

  • Shao Liang Chen

Principal Investigators

  • N/A

Medical Centers

  • Nanjing First Hospital, Nanjing Medical University, Nanjing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Rapacan

  • Probucol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved